Therapeutic compliance, the European Beamer project was born to improve it

Rome, November 23 –Innovative Drugs Initiative (Imi), a project launched in 2007 by the European Commission in collaboration with Efipia, the European Federation of Pharmaceutical Industries and Associations, announces the launch of a promising project aimed at improving patients’ adherence to medicines, whose lack of (non-compliance) is associated with adverse patient outcomes and significant costs.